Lonza Group AG (OTCMKTS:LZAGY) Sees Large Increase in Short Interest

Lonza Group AG (OTCMKTS:LZAGY) was the target of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 7,900 shares, an increase of 64.6% from the March 31st total of 4,800 shares. Based on an average daily trading volume, of 186,200 shares, the short-interest ratio is currently 0.0 days.

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft upgraded shares of Lonza Group from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd.

Lonza Group Trading Up 2.3 %

Shares of OTCMKTS LZAGY traded up $1.29 during mid-day trading on Friday, hitting $57.79. 33,920 shares of the stock were exchanged, compared to its average volume of 80,847. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.20 and a current ratio of 1.77. Lonza Group has a twelve month low of $34.19 and a twelve month high of $66.00. The stock’s fifty day simple moving average is $55.91 and its two-hundred day simple moving average is $46.62.

About Lonza Group

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.